Day one

last modified: 17 September '12

Please enable javascript to see more information on speakers

8.50am
Opening remarks from the chair
9am
Keynote: In depth review of the new European pharmacovigilance legislation
Ennis Lee at World Drug Safety Congress Europe

Ennis Lee

Dr Ennis Lee qualified from Westminster Medical School and practised in the NHS in general medicine and medical oncology. Dr Lee joined the pharmaceutical industry over 25 years ago and has worked for several major pharmaceutical companies, in all ...

more..
9.20am
PANEL: Operational implications for integration of the new European pharmacovigilance legislation for pharma
Omer De Mol at World Drug Safety Congress Europe
Astrid Herpers at World Drug Safety Congress Europe
Vicki Edwards at World Drug Safety Congress Europe

Vicki Edwards

Vicki Edwards qualified as a pharmacist in 1981 and started her career in hospital pharmacy. In 1983 she specialised in Drug Information Services and moved to Kuwait to set up and run the first National Drug Information Centre. The Centre became a ...

more..
Katrien Solemé at World Drug Safety Congress Europe

9.50am
CCDS, PSUR, RMP, DSUR, signal validation: Interrelations, modules and impact of the new GVP
Véronique Basch at World Drug Safety Congress Europe

Véronique Basch

Véronique Basch, PharmD, is the Executive Director, Pharmacovigilance for United BioSource Corporation and is based in Geneva, Switzerland. She manages the development, implementation, and execution of UBC’s safety strategy, providing...

more..
10.20am
Morning refreshments and speed networking
11.20am
Legislative requirements for the pharmacovigilance system with focus on the Pharmacovigilance System Master File
Ralph Nies at World Drug Safety Congress Europe

Ralph Nies

Ralph is 49y old and is a physician by training . He has worked for 6 years in hospital, before he joined the Pharmaceutical Industry in 1998 as a Pharmacovigilance Physician for Chiron-Behring (now Novartis Vaccines) in Marburg (Germany). From 2001 ...

more..
11.40am
The new PSUR: key amendments following the EU pharmacovigilance legislation changes
Jean-Marie Heim at World Drug Safety Congress Europe

Jean-Marie Heim

Jean-Marie Heim, MD is currently Medical Director, Safety Assessment, responsible for the global cardio-vascular and metabolic mature BMS portfolio, handling over 20 drugs. He is a trained physician from the Brussels University specialized in...

more..
12pm
Implementation of DSURs in Europe and with it the new developments placed on pharmacovigilance in the approval of new medicinal products
Barbara de Bernardi at World Drug Safety Congress Europe
12.20pm
Keynote: Expectations of Health Authorities from the strengthening of the QPPV role
Ute Hoeffner at World Drug Safety Congress Europe
12.40pm
Transparency in the EU
Rudi Scheerlinck at World Drug Safety Congress Europe
1pm
Lunch
last modified: 17 September '12